Activity Report and Latest Information

Dr. Tatsuya Yamashita worked at Global Hepatitis Programme in WHO Headquarters as first secondee from Kanazawa University for six months. He contributed to parts of algorithm and monitoring for drug toxicity in WHO HBV guidelines．He also tried to develop guidelines for advanced liver diseases in planned hepatitis consolidated guidelines as leader. The guidelines finally stopped to develop because of budget shortness. He also applied HBV treatment drug “entecavir” in WHO essential medicine lists.